Semaglutide vs Liraglutide: Which GLP-1 Medication Is Better for Weight Loss?

Two GLP-1 Medications, Very Different Results

Semaglutide and liraglutide are both GLP-1 receptor agonists. They both reduce appetite, slow gastric emptying, and help people lose weight. But they are not interchangeable, and the differences matter more than most people realize.

If you are trying to decide between the two, or wondering why your doctor recommended one over the other, here is the honest comparison.

The Basics

Liraglutide (Saxenda) was the first GLP-1 approved specifically for weight management. It is a daily injection, meaning you give yourself a shot every single day.

Semaglutide (Wegovy) came later and is a weekly injection. One shot per week. Same class of drug, but a modified molecule that lasts much longer in the body.

Both are also available in formulations for type 2 diabetes (Victoza for liraglutide, Ozempic for semaglutide), but the weight loss versions are dosed differently.

Weight Loss: Semaglutide Wins

This is not a close call. The clinical data is clear.

In the STEP trials, semaglutide at the 2.4mg weekly dose produced an average weight loss of about 15 to 17 percent of body weight over 68 weeks.

In the SCALE trials, liraglutide at the 3.0mg daily dose produced an average weight loss of about 5 to 8 percent of body weight over 56 weeks.

That is a significant gap. For a 250-pound person, semaglutide might mean losing 37 to 42 pounds, while liraglutide might mean losing 12 to 20 pounds. Same class of medication. Very different outcomes.

Dosing and Convenience

Liraglutide requires a daily injection. Every day. If you miss a day, you skip it and resume the next day. The dose is titrated up over several weeks from 0.6mg to the target of 3.0mg.

Semaglutide requires a weekly injection. Pick a day, give yourself the shot, and you are done for the week. Dose titration goes from 0.25mg weekly up to 2.4mg weekly over about 16 to 20 weeks.

For most patients, once weekly is dramatically easier to stick with. Compliance matters more than people think. The best medication in the world does nothing if you stop taking it.

Side Effects: Similar but Not Identical

Both medications share the classic GLP-1 side effect profile: nausea, vomiting, diarrhea, constipation. These are most common during dose increases and tend to improve over time.

Semaglutide tends to cause more GI side effects at higher doses, likely because it is simply a more potent medication. But the slower dose titration helps manage this.

Liraglutide has a slightly higher rate of injection site reactions, probably because you are injecting daily instead of weekly.

Both carry warnings about pancreatitis and thyroid tumors (based on animal studies). Neither should be used in patients with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.

Cost Comparison

Brand-name pricing for both is steep. Saxenda and Wegovy can both run over $1,000 per month without insurance. Some insurance plans cover one but not the other, and coverage varies wildly.

Compounded semaglutide has become available at lower price points, which has shifted the landscape. Compounded liraglutide is less commonly available because the daily dosing and lower efficacy make it a less attractive option for compounding pharmacies.

If cost is a major factor, semaglutide generally offers more bang for your buck, both in terms of clinical results and the availability of compounded options.

When Liraglutide Might Still Make Sense

There are a few scenarios where liraglutide could be the right choice:

• You cannot tolerate semaglutide. Some patients get severe nausea on semaglutide that does not resolve. Switching to liraglutide sometimes works because the daily dosing creates a more steady-state drug level.
• You want more control over your dose. Daily dosing means you can make smaller, more frequent adjustments. Some patients prefer this.
• Your insurance covers Saxenda but not Wegovy. Practical reality sometimes overrides clinical preference.
• You need a shorter-acting option. If you experience a serious side effect, liraglutide clears your system faster than semaglutide. With a weekly medication, you are committed for the full week.

What About Oral Semaglutide?

Oral semaglutide (Rybelsus) exists for type 2 diabetes and is being studied for weight management at higher doses. It eliminates injections entirely but has specific requirements: you must take it on an empty stomach with no more than 4 ounces of water, then wait 30 minutes before eating or drinking anything else.

The oral bioavailability is lower, so higher doses are needed. Some patients prefer the convenience of no injections despite the fasting requirement.

The Bottom Line

For most patients seeking weight loss, semaglutide is the stronger option. It produces more weight loss, requires fewer injections, and has a more robust evidence base for long-term outcomes.

But medicine is not one-size-fits-all. Your medical history, insurance situation, side effect tolerance, and personal preferences all matter.

At Coral, we walk through these options with you during your telehealth visit. No generic protocols. We figure out what makes sense for your specific situation and adjust as needed. If you are ready to have that conversation, book a visit and let us help you find the right fit.